The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Diabetes and Hypertension: A Position Statement by the American Diabetes Association
Open accessAbstract
Hypertension is common among patients with diabetes, with the prevalence depending on type and duration of diabetes, age, sex, race/ethnicity, BMI, history of glycemic control, and the presence of kidney disease, among other factors (1-3).Furthermore, hypertension is a strong risk factor for atherosclerotic cardiovascular disease (ASCVD), heart failure, and microvascular complications.ASCVDddefined as acute coronary syndrome, myocardial infarction (MI), angina, coronary or other arterial revascularization, stroke, transient ischemic attack, or peripheral arterial disease presumed to be of atherosclerotic origindis the leading cause of morbidity and mortality for individuals with diabetes and is the largest contributor to the direct and indirect costs of diabetes.Numerous studies have shown that antihypertensive therapy reduces ASCVD events, heart failure, and microvascular complications in people with diabetes (4-8).Large benefits are seen when multiple risk factors are addressed simultaneously (9).There is evidence that ASCVD morbidity and mortality have decreased for people with diabetes since 1990 (10,11) likely due in large part to improvements in blood pressure control (12-14).This Position Statement is intended to update the assessment and treatment of hypertension among people with diabetes, including advances in care since the American Diabetes Association (ADA) last published a Position Statement on this topic in 2003 (3). DEFINITIONS, SCREENING, AND DIAGNOSISRecommendations c Blood pressure should be measured at every routine clinical care visit.Patients found to have an elevated blood pressure ($140/90 mmHg) should have blood pressure confirmed using multiple readings, including measurements on a separate day, to diagnose hypertension.B c All hypertensive patients with diabetes should have home blood pressure monitored to identify white-coat hypertension.B c Orthostatic measurement of blood pressure should be performed during initial evaluation of hypertension and periodically at follow-up, or when symptoms of orthostatic hypotension are present, and regularly if orthostatic hypotension has been diagnosed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is strong evidence from clinical trials of the value of treating hypertension in older adults (70,71), with treatment of hypertension to individualized target levels indicated in most.”
From 13. Older Adults: Standards of Care in Diabetes—2024 (2024) · cites this paper as [71]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is strong evidence from clinical trials of the value of treating hypertension in older adults (72,73), with treatment of hypertension to individualized target levels indicated in most.”
From 13. Older Adults: Standards of Care in Diabetes—2025 (2025) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is strong evidence from clinical trials of the value of treating hypertension in older adults”
From 13. Older Adults: Standards of Care in Diabetes—2026 (2026) · cites this paper as [80]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Antihypertensive therapy reduces the risk of albuminuria (67)(68)(69)(70), and among people with type 1 or 2 diabetes with established CKD (eGFR <60 mL/min/1.73m 2 and UACR $300 mg/g creatinine), ACE inhibitor or ARB therapy reduces the risk of progression to ESKD (71)(72)(73)(74)(75)(76)(77)(78)(79)(80).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [70]
The cited source says what the claim attributes to it.
In the citing paper
“For individuals with albuminuria (urine albumin-to-creatinine ratio [UACR] $30 mg/g), initial treatment should include an ACE inhibitor or ARB to reduce the risk of progressive kidney disease (21) (Fig. 10.2).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [21]
In the citing paper
“For patients with albuminuria (urine albumin-to-creatinine ratio [UACR] $ 30 mg/g), initial treatment should include an ACE inhibitor or ARB to reduce the risk of progressive kidney disease (20) ( Fig. 10.2 ).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Flagged first, then by citations
Research works printed but not linked: 1
- Lin JS, O’Connor EA, Evans CV, Senger CA, Rowland MG, Groom HC. Behavioral Counseling to Promote a Healthy Lifestyle for Cardiovascular Disease Prevention in Persons With Cardiovascular Risk Factors: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet], 2014. Rockville, MD, Agency for Healthcare Research and Quality (US), 2014. Available from http://www.ncbi.nlm.nih.gov/books/NBK241537/. Accessed 11 November 2016
Cited by
Sorted by citations
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Gomes, M. A. M., Brandão, A. A., Feitosa, A. D. M., Machado, C. A., Poli‐de‐Figueiredo, C. E., Amodeo, C., Mion, D., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201238 · Cited by 1,389
de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, P., & Bakris, G. (2022) · Diabetes Care · doi:10.2337/dci22-0027 · Cited by 919
“The ADA includes BP recommendations in each annual Standards of Care and published a position statement on diabetes and hypertension in 2017.(38) BP control was highlighted as a key component of comprehensive care in the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease and KDIGO…”
BackgroundSelf-citation10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s010 · Cited by 869
Joseph, J. J., Deedwania, P., Acharya, T., Aguilar, D., Bhatt, D. L., Chyun, D. A., Di Palo, K. E., Golden, S. H., Sperling, L. S., & on behalf of the American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Arteriosclerosis, T. A. V. B. C. O. C. C. A. C. O. H. (2022) · Circulation · doi:10.1161/cir.0000000000001040 · Cited by 660
Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline
LeRoith, D., Biessels, G. J., Braithwaite, S. S., Casanueva, F. F., Draznin, B., Halter, J. B., Hirsch, I. B., McDonnell, M. E., Molitch, M. E., Murad, M. H., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00198 · Cited by 616
Chiang, J. L., Maahs, D. M., Garvey, K. C., Hood, K. K., Laffel, L. M., WEINZIMER, S. A., Wolfsdorf, J. I., & Schatz, D. (2018) · Diabetes Care · doi:10.2337/dci18-0023 · Cited by 565
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s010 · Cited by 495
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s010 · Cited by 487
9. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2018
(2017) · Diabetes Care · doi:10.2337/dc18-s009 · Cited by 505
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s010 · Cited by 471
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Das, S. R., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s010 · Cited by 465
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes−2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s011 · Cited by 460
Treatment of hypertension: a review
Carey, R. M., Moran, A. E., & Whelton, P. K. (2022) · JAMA · doi:10.1001/jama.2022.19590 · Cited by 455
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Das, S. R., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s010 · Cited by 438
Pop‐Busui, R., Januzzi, J. L., Bruemmer, D., Butalia, S., Green, J. B., Horton, W. B., Knight, C. M., Levi, M., Rasouli, N., & Richardson, C. R. (2022) · Diabetes Care · doi:10.2337/dci22-0014 · Cited by 442
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc19-s011 · Cited by 416
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s011 · Cited by 395
13. Older Adults: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s013 · Cited by 381
de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, P. R., & Bakris, G. L. (2022) · Kidney International · doi:10.1016/j.kint.2022.08.012 · Cited by 389
Self-citationThe actions of SGLT2 inhibitors on metabolism, renal function and blood pressure
Thomas, M. C., & Cherney, D. Z. I. (2018) · Diabetologia · doi:10.1007/s00125-018-4669-0 · Cited by 366
11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s011 · Cited by 344
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Das, S. R., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s010 · Cited by 339
ACC/AHA Versus ESC/ESH on Hypertension Guidelines
Bakris, G. L., Ali, W., & Parati, G. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.507 · Cited by 322
Self-citation10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc18-s010 · Cited by 316
Hypertension Across a Woman’s Life Cycle
WENGER, N. K., Arnold, A. M., Merz, C. N. B., Cooper‐DeHoff, R. M., Ferdinand, K. C., Fleg, J. L., Gulati, M., Isiadinso, I., Itchhaporia, D., Light-McGroary, K., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.033 · Cited by 318
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D. M., Johnson, E. L., et al. (2022) · Diabetes Care · doi:10.2337/dc23-s011 · Cited by 310
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2024
ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., Lingvay, I., et al. (2023) · Diabetes Care · doi:10.2337/dc24-s011 · Cited by 324
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s011 · Cited by 318
Plant-based meat analogue (PBMA) as a sustainable food: a concise review
Singh, M., Trivedi, N., Enamala, M. K., Kuppam, C., Parikh, P., Nikolova, M. P., & Chavali, M. S. (2021) · European Food Research and Technology · doi:10.1007/s00217-021-03810-1 · Cited by 262
Type 2 Diabetes and Hypertension: A Study on Bidirectional Causality
Sun, D., Zhou, T., Heianza, Y., Li, X., Fan, M., Fonseca, V. A., & Qi, L. (2019) · Circulation Research · doi:10.1161/circresaha.118.314487 · Cited by 252
Timpel, P., Oswald, S., Schwarz, P. E. H., & Harst, L. (2020) · Journal of Medical Internet Research · doi:10.2196/16791 · Cited by 243
9. Cardiovascular Disease and Risk Management
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s012 · Cited by 223
12. Older Adults: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc20-s012 · Cited by 228
12. Older Adults: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc19-s012 · Cited by 220
12. Older Adults: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc21-s012 · Cited by 234
13. Older Adults: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s013 · Cited by 209
Kostov, K. G., & Halacheva, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061724 · Cited by 206
13. Older Adults: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D. M., Johnson, E. L., et al. (2022) · Diabetes Care · doi:10.2337/dc23-s013 · Cited by 223
Guideline-Driven Management of Hypertension
Carey, R. M., Wright, J. T., Taler, S. J., & Whelton, P. K. (2021) · Circulation Research · doi:10.1161/circresaha.121.318083 · Cited by 224
De Nardi, A. T., Tolves, T., Lenzi, T. L., Signori, L. U., & Silva, A. M. V. D. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.12.017 · Cited by 191
Kidney disease in diabetes: From mechanisms to clinical presentation and treatment strategies
Ricciardi, C. A., & Gnudi, L. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154890 · Cited by 198
Tsapas, A., Karagiannis, T., Kakotrichi, P., Avgerinos, I., Mantsiou, C., Tousinas, G., Manolopoulos, A., Liakos, A., Malandris, K., Matthews, D. R., et al. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14451 · Cited by 179
13. Older Adults: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s013 · Cited by 161
Chinese Guidelines for the Prevention and Treatment of Hypertension (2024 revision)
Wang, J. (2025) · 老年心脏病学杂志：英文版 · doi:10.26599/1671-5411.2025.01.008 · Cited by 170
Blood pressure and heart failure
Oh, G. C., & Cho, H. (2020) · Clinical Hypertension · doi:10.1186/s40885-019-0132-x · Cited by 167
Cardiovascular Risk in Type 1 Diabetes Mellitus
Schofield, J. D., Ho, J. H., & Soran, H. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0612-8 · Cited by 164
Nazarzadeh, M., Bidel, Z., Canoy, D., Copland, E., Wamil, M., Majert, J., Smith-Byrne, K., Sundström, J., Teo, K. K., Davis, B. R., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01920-6 · Cited by 153
Beddhu, S., Greene, T., Boucher, R., Cushman, W. C., Wei, G., Stoddard, G., Ix, J. H., Chonchol, M., Kramer, H., Cheung, A. K., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30099-8 · Cited by 128
Redefining diuretics use in hypertension
Burnier, M., Bakris, G. L., & Williams, B. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002088 · Cited by 123
Self-citationYe, N., Jardine, M. J., Oshima, M., Hockham, C., Heerspink, H. J. L., Agarwal, R., Bakris, G., Schutte, A. E., Arnott, C., Chang, T. I., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.048740 · Cited by 115
Self-citationAkalu, Y., & Belsti, Y. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s254537 · Cited by 126
Magnesium and Hypertension in Old Age
Dominguez, L. J., Veronese, N., & Barbagallo, M. (2020) · Nutrients · doi:10.3390/nu13010139 · Cited by 119
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s011 · Cited by 108
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s010 · Cited by 107
Hypertension in patients with type 2 diabetes mellitus: Targets and management
Pavlou, D. I., Paschou, S. Α., Anagnostis, P. G., Spartalis, Μ., Spartalis, E. D., Vryonidou, A., Tentolouris, N., & Siasos, G. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.03.013 · Cited by 113
Hypertension Management in Diabetes: 2018 Update
Passarella, P., Киселева, Т. А., Valeeva, F. V., & Gosmanov, A. R. (2018) · Diabetes Spectrum · doi:10.2337/ds17-0085 · Cited by 107
Redefining Hypertension — Assessing the New Blood-Pressure Guidelines
Bakris, G. L., & Sorrentino, M. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmp1716193 · Cited by 100
Self-citationChamberlain, J. J., Johnson, E. L., Leal, S., Rhinehart, A. S., Shubrook, J. H., & Peterson, L. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0222 · Cited by 105
Vesa, C. M., Popa, L., Popa, A. R., Rus, M., Zaha, A. A., BUNGAU, S. G., Ţiţ, D. M., Aron, R. A. C., & Zaha, D. C. (2020) · Diagnostics · doi:10.3390/diagnostics10050314 · Cited by 101
Future Direction for Using Artificial Intelligence to Predict and Manage Hypertension
Krittanawong, C., Bomback, A. S., Baber, U., Bangalore, S., Messerli, F. H., & Tang, W. H. W. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0875-x · Cited by 96
Self-citationBjornstad, P., Donaghue, K. C., & Maahs, D. M. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30035-4 · Cited by 99
Natural history of prediabetes in older adults from a population‐based longitudinal study
Shang, Y., Marseglia, A., Fratiglioni, L., Welmer, A., Wang, R., Wang, H., & Xu, W. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12920 · Cited by 100
Hassan, A., & Khan, T. (2020) · IEEE Access · doi:10.1109/access.2020.3035026 · Cited by 91
13. Older Adults: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s013 · Cited by 87
Hypertension and Type 2 Diabetes—The Novel Treatment Possibilities
Przezak, A., Bielka, W., & Pawlik, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126500 · Cited by 97
Pimentel, F. B., Alves, R. C., Harnedy, P. A., FitzGerald, R. J., & Oliveira, M. B. P. P. (2019) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2019.09.006 · Cited by 81
A machine learning-based on-demand sweat glucose reporting platform
Sankhala, D., Sardesai, A. U., Pali, M. L., Lin, K., Jagannath, B., Muthukumar, S., & Prasad, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-06434-x · Cited by 84
Juraschek, S. P., Cortez, M. M., Flack, J. M., Ghazi, L., Kenny, R. A., Rahman, M., Spikes, T. A., Shibao, C. A., & Biaggioni, I. (2024) · Hypertension · doi:10.1161/hyp.0000000000000236 · Cited by 92
Predicting and preventing heart failure in type 2 diabetes
Pandey, A., Khan, M. S., Patel, K. V., Bhatt, D. L., & Verma, S. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00128-6 · Cited by 84
Disparities in Prevalence and Barriers to Hypertension Control: A Systematic Review
Elnaem, M. H., Mosaad, M., Abdelaziz, D. H., Mansour, N. O., Abubakar, U., Elrggal, M. E., & Cheema, E. U. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192114571 · Cited by 75
Or, C. K., Liu, K., So, M. K. P., Cheung, B. M. Y., Yam, L. Y.-C., Tiwari, A., Lau, Y. F. E., Lau, T., Hui, P. S. G., Cheng, H. C., et al. (2020) · Journal of Medical Internet Research · doi:10.2196/16769 · Cited by 79
The Landscape of Diabetic Kidney Disease in the United States
Duru, O. K., Middleton, T. R., Tewari, M. K., & Norris, K. C. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0980-x · Cited by 75
Hypertension and diabetes mellitus: highlights of a complex relationship
Yildiz, M., Esenboğa, K., & Oktay, A. A. (2020) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000748 · Cited by 75
Ferreira, N. S., Bruder-Nascimento, T. B., Pereira, C. A., Zanotto, C. Z., Prado, D. D. S., da Silva, J. F., Rassi, D. M., Foss‐Freitas, M. C., Alves-Filho, J. C., Carlos, D., et al. (2019) · Cells · doi:10.3390/cells8121595 · Cited by 70
Shoily, S. S., Ahsan, T., Fatema, K., & Sajib, A. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-86801-2 · Cited by 69
Prevention of Cardiovascular Disease in Type 1 Diabetes
Manrique‐Acevedo, C., Hirsch, I. B., & Eckel, R. H. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2311526 · Cited by 69
Control of 24-hour blood pressure with SGLT2 inhibitors to prevent cardiovascular disease
Kario, K., Ferdinand, K. C., & O’Keefe, J. H. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.04.003 · Cited by 69
Muntner, P., Whelton, P. K., Woodward, M., & Carey, R. M. (2018) · Diabetes Care · doi:10.2337/dc18-1307 · Cited by 65
Self-citationLamprea-Montealegre, J. A., Zelnick, L. R., Hall, Y. N., Bansal, N., & de Boer, I. H. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11609 · Cited by 66
Nurse-Led Diabetes Self-Management Education Improves Clinical Parameters in Ethiopia
Hailu, F. B., Hjortdahl, P., & Moen, A. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00302 · Cited by 62
Ashrafizadeh, M., Najafi, M., Kaviyani, N., Mohammadinejad, R., Farkhondeh, T., & Samarghandian, S. (2021) · Inflammation · doi:10.1007/s10753-021-01428-9 · Cited by 66
RetractedBakhsh, A., Lee, E.-Y., Ncho, C. M., Kim, C.-J., Son, Y.-M., Hwang, Y.-H., & Joo, S.-T. (2022) · Foods · doi:10.3390/foods11091242 · Cited by 61
Treatment of Hypertension in Chronic Kidney Disease
Kalaitzidis, R., & Elisaf, M. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0864-0 · Cited by 61
Cao, Q., Huang, C., Chen, X., & Pollock, C. A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.816656 · Cited by 58
Lingvay, I., Mosenzon, O., Brown, K., Cui, X., O’Neill, C., Fernández Landó, L., & Patel, H. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01797-5 · Cited by 55
“Hypertension is a strong risk factor for microvascular and macrovascular diabetic complications, including retinopathy, nephropathy and atherosclerotic cardiovascular disease [3, 4].”
BackgroundVanWagner, L. B., Holl, J. L., Montag, S., Gregory, D., Connolly, S., Kosirog, M., Campbell, P., Pine, S., Daud, A., Finn, D., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15706 · Cited by 55
Pathophysiological Links Between Diabetes and Blood Pressure
Libianto, R., Batu, D., MacIsaac, R. J., Cooper, M. E., & Ekinci, E. I. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.01.010 · Cited by 56
Diabetes mellitus type 2 in adults
Dedov, I. I., Shestakova, M. V., Mayorov, A. Y., Шамхалова, М. Ш., Sukhareva, O. Y., Galstyan, G. R., Tokmakova, A. Y., Nikonova, T. V., Surkova, E. V., Кононенко, И. В., et al. (2020) · Diabetes Mellitus · doi:10.14341/dm12507 · Cited by 60
de Boer, I. H., Bakris, G., & Cannon, C. P. (2018) · JAMA · doi:10.1001/jama.2018.0642 · Cited by 54
Self-citationImpact of diabetes mellitus on mortality rates and outcomes in myocardial infarction
Schmitt, V. H., Hobohm, L., Münzel, T. F., Wenzel, P., Gori, T., & Keller, K. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.11.003 · Cited by 59
Khan, M. N., Oldroyd, J. C., Chowdhury, E., Hossain, M. B., Rana, J., Renzetti, S., & Islam, R. M. (2021) · Journal of Clinical Hypertension · doi:10.1111/jch.14363 · Cited by 53
Hezam, A. A. M., Shaghdar, H. B. M., & Chen, L. (2024) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_470_23 · Cited by 65
Documento de abordaje integral de la diabetes tipo 2
Reyes‐García, R., Moreno, Ó., Pérez, C. T., Fernández‐García, D., Bellido, V., Casares, M. L. D. L. T., Rozas-Moreno, P., Fernández‐García, J. C., Martínez, A. M., Escalada, J., et al. (2019) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2018.10.010 · Cited by 54
Curovic, V. R., Theilade, S., Winther, S. A., Tofte, N., Eugen‐Olsen, J., Persson, F., Hansen, T. W., Jeppesen, J., & Rossing, P. R. (2019) · Diabetes Care · doi:10.2337/dc18-1427 · Cited by 50
Self-citationYonekawa, Y., Modi, Y. S., Kim, L. A., Skondra, D., Kim, J. E., & Wykoff, C. C. (2020) · Journal of VitreoRetinal Diseases · doi:10.1177/2474126419893829 · Cited by 49
Ramkanth, S., Anitha, P., Gayathri, R., Mohan, S., & Babu, D. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105811 · Cited by 49
Rahman, F., McEvoy, J. W., Ohkuma, T., Marre, M., Hamet, P., Harrap, S., Mancia, G., Rodgers, A., Selvin, E., Williams, B., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12414 · Cited by 48
Self-citationDebon, R., Bellei, E. A., Biduski, D., Volpi, S. S., Alves, A. L. S., Portella, M. R., & Marchi, A. C. B. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-63057-w · Cited by 52
Berra, C., Manfrini, R., Regazzoli, D., Radaelli, M. G., Disoteo, O., Sommese, C., Fiorina, P., Ambrosio, G., & Folli, F. B. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105052 · Cited by 51
Metadata
- Authors
- de Boer, I. H., Bangalore, S., Benetos, A., Davis, A. M., Michos, E. D., Muntner, P., Rossing, P., Zoungas, S., & Bakris, G.
- Affiliations
- University of Washington, Seattle, WA
- New York University (US)
- Université de Lorraine, Nancy, France
- University of Chicago (US)
- Johns Hopkins University (US)
- University of Alabama at Birmingham (US)
- University of Copenhagen (DK)
- Monash University (AU)
- Corresponding author
- Bakris, George
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-08-14
- Volume
- 40
- Issue
- 9
- Pages
- 1273-1284
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2748201042
- Semantic Scholar
- 4e3c7fd3bbe3119a559b61514192347b33e3e619
- Cited by
- 714
- References
- 145
- Citations by year
- 2026: 30 · 2025: 67 · 2024: 89 · 2023: 69 · 2022: 102 · 2021: 113 · 2020: 83 · 2019: 81 · 2018: 71 · 2017: 5
- FWCI
- 9.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Monash University Research Portal (Monash University) (submittedVersion, other-oa)
- Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Ironwood Pharmaceuticals, Incorporated
- Medicines Company
- Steno Diabetes Center Copenhagen (SDCC 3.A Complications)
- Novo Nordisk
- Astellas Pharma
- Novo Nordisk Fonden (NNF14OC0013659)
- Servier
- Sanofi Australia
- Abbott Vascular
- Defense Acquisition Program Administration
- Relypsa
- National Heart, Lung, and Blood Institute
- Cilag
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- hypertension, diabetes mellitus, atherosclerotic cardiovascular disease, heart failure, microvascular complications, antihypertensive therapy, blood pressure screening, home blood pressure monitoring, white coat hypertension, orthostatic hypotension, blood pressure control, risk factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
